Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Validation of a Bruton's disease genetic analysis method].

C Rodriguez1, C d'Audigier, V Bertrand

  • 1Laboratoire d'Immunologie Cellulaire et Tissulaire, Groupe Hospitalier Pitié-Salpêtrière (AP-HP), Paris. christophe_rod@yahoo.fr

Annales De Biologie Clinique
|October 17, 2006
PubMed
Summary

Genetic sequencing of the Bruton's tyrosine kinase (BTK) gene identified mutations responsible for X-linked agammaglobulinemia (XLA). This validated a sequencing technique and aids in diagnosing this primary immunodeficiency.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Underestimation of plasma level of factor V coagulant activity and fibrinogen concentration together with prolonged prothrombin time, activated partial thromboplastin time and thrombin time can result from pre-analytical very low calcium level in citrated sample tube.

International journal of laboratory hematology·2015
Same author

The profibrotic cytokine transforming growth factor-β1 increases endothelial progenitor cell angiogenic properties.

Journal of thrombosis and haemostasis : JTH·2012
Same author

Angiogenic potential of BM MSCs derived from patients with critical leg ischemia.

Bone marrow transplantation·2011
Same author

[Primary immunodeficiencies and Bruton's disease genetic analysis: which prospects offers this genetic diagnosis?].

Annales de biologie clinique·2006
Same author

Apoptosis in primary lymphoid organs with aging.

Microscopy research and technique·2003
Same author

Transplant procurement management: a model for organ and tissue shortage.

Transplantation proceedings·2003

Area of Science:

  • Immunology
  • Genetics
  • Molecular Biology

Background:

  • Bruton's disease, or X-linked agammaglobulinemia (XLA), is a primary immunodeficiency characterized by recurrent infections due to severe B-cell deficiency.
  • Over 400 mutations in the Bruton's tyrosine kinase (BTK) gene have been identified as causative agents of XLA.
  • Patients exhibit hypo/agammaglobulinemia, increasing susceptibility to early and recurring infections.

Purpose of the Study:

  • To validate a genetic sequencing technique for identifying BTK gene mutations in XLA patients.
  • To establish a strategy for analyzing mutation multiplicity for clearer clinical results.
  • To support genetic counseling and improve understanding of XLA.

Main Methods:

  • Genetic sequencing of the BTK gene (19 exons and adjacent introns) in a cohort of five XLA patients and two parents (NECKER group).

Related Experiment Videos

  • Polymerase chain reaction (PCR) amplification followed by PCR-sequencing using universal primers.
  • Comparison of NECKER group sequencing data with previously reported Italian data for technique validation.

    • Main Results:

    • The study successfully validated the PCR and sequencing methodology by demonstrating equivalent results between the NECKER group and Italian data.
    • Confirmed the utility of the sequencing technique for identifying various mutations within the BTK gene.
    • Highlighted the need for precise analysis of mutation multiplicity (coding/non-coding, described/undescribed) for clinical application.

    Conclusions:

    • The validated genetic sequencing strategy provides clear and trustworthy results for clinicians diagnosing XLA.
    • This approach aids in managing uncertain diagnoses of primary immunodeficiencies.
    • Facilitates genetic counseling for families and contributes to building a comprehensive XLA database for better disease understanding.